Visniauskas B et al. Estrogen-mediated mechanisms in hypertension and other cardiovascular diseases. Journal of Human Hypertension, 2022. https://www.nature.com/articles/s41371-022-00771-0
Key takeaways
- Oestrogen actively protects blood vessel health. When it declines at menopause, blood pressure typically rises, independently of ageing or weight.
- If you are considering HRT and have elevated blood pressure, formulation matters significantly. Transdermal HRT (patches, gels, or sprays) can have a neutral effect on blood pressure; oral tablets may mildly raise it in some women.
- High blood pressure during menopause is manageable, and the right treatment plan, combining hormonal support, dietary changes, and where needed medication, can produce meaningful improvements in cardiovascular health.
Why menopause and high blood pressure are connected
Before menopause, women typically have lower blood pressure than men of the same age. That difference largely disappears after menopause. The mechanism is not coincidental.
Oestrogen plays an active protective role in blood vessel health. Research published in the Journal of Human Hypertension confirmed that oestrogen can help protect the heart and blood vessels by acting on receptors in the vessel walls. This encourages the body to produce natural substances, including nitric oxide and prostacyclin, which help blood vessels relax, stay flexible, and widen when neededWhen oestrogen declines, this mechanism weakens. Blood vessels become less responsive, arterial stiffness increases, and blood pressure rises.
A 2025 narrative review in Biomedicines described how changes during menopause, along with ageing, metabolism, and changing hormone levels, can affect blood vessel health, the body’s hormone regulation, and blood flow The result is not just a single pathway but a converging set of mechanisms that collectively raise blood pressure risk in midlife women.
Cross-sectional evidence suggests that menopause approximately doubles hypertension risk (high blood pressure), independent of age and BMI. This is not simply a matter of getting older. Menopause itself is a significant cardiovascular inflection point.
It is not just about hormones: the other reasons blood pressure rises
The oestrogen decline is the primary driver, but several other menopause-related changes compound it.
Weight and body fat redistribution
Menopause is associated with a shift in body fat distribution towards the abdomen, driven by changes in oestrogen and insulin signalling. Abdominal fat is more metabolically active than fat stored elsewhere and is directly associated with elevated blood pressure and insulin resistance. This is a hormonal and metabolic process, not simply a lifestyle consequence.
Sleep disruption
Poor sleep activates the sympathetic nervous system, elevates cortisol, and raises blood pressure. The relationship runs in both directions: disrupted sleep raises BP, and elevated BP can itself disturb sleep. Night sweats and hot flushes are a direct cause of sleep disruption for many menopausal women, creating a cycle that compounds cardiovascular risk.
Stress and cortisol
Perimenopause is often accompanied by significant life pressures (parenting, caring responsibilities, professional demands) alongside the hormonal changes that make those pressures harder to manage. Elevated cortisol from chronic stress is directly associated with hypertension. The Biomedicines 2025 review highlighted changes in the body’s hormones and nervous system during menopause can play an important role in increasing blood pressure
Hot flushes as a blood pressure risk modifier
This is less widely known: the American Heart Association's 2020 scientific statement noted that frequent, severe, or long-lasting vasomotor symptoms (hot flushes and night sweats) are associated with greater cardiovascular risk, including hypertension, beyond the effect of menopause alone. Managing vasomotor symptoms effectively is therefore not only a quality-of-life question. It may also be a cardiovascular health question.
Why it matters: the cardiovascular risks of raised blood pressure after menopause
High blood pressure in midlife women is not the same risk it was at 35. Post-menopausal women experience cardiovascular events at lower blood pressure thresholds than pre-menopausal women, meaning that a reading that would have been closely monitored but not urgently treated at an earlier age carries more clinical significance after menopause.
A UK Biobank prospective cohort study published in Atherosclerosis, following over 156,000 women for 12.5 years, confirmed that cardiovascular risk increases during menopause and is shaped by female-specific risk factors that standard cardiovascular models, calibrated largely on male populations, may underestimate.
“The consequences of unmanaged hypertension are serious and cumulative: heart disease, stroke, kidney disease, and vascular dementia are all associated with sustained elevated blood pressure. None of this is inevitable. It is mentioned not to alarm, but to make clear why monitoring and proactive management during and after menopause genuinely matters.”
High blood pressure often causes no noticeable symptoms, which is why it can go undetected without regular measurement. The only way to know your numbers is to check them.
Knowing your numbers: blood pressure monitoring during menopause
Blood pressure is measured in two numbers. The systolic pressure (the higher number) measures the force of blood against artery walls when the heart beats. The diastolic pressure (the lower number) measures the same when the heart rests between beats. A reading of around 120/80 mmHg is considered typical for most adults; 135/85 mmHg and above is generally considered elevated. Neither number is of more importance; both are equally important.
Regular monitoring matters. A GP, practice nurse, or pharmacy can check blood pressure, but home blood pressure monitoring is most accurate and monitors are widely available. Research published in the American Journal of Preventive Cardiology (2025) found that women showed larger blood pressure reductions than men when actively managing hypertension through home-monitoring, suggesting that proactive engagement with blood pressure data is particularly meaningful for women.
For a broader cardiovascular picture, Voy's Women's Midlife MOT Blood Test measures 16 biomarkers including total cholesterol, HDL, LDL, triglycerides, and the total cholesterol to HDL ratio, alongside hormonal markers. For women aged 40 and over who want to understand their full cardiovascular risk profile, not just a single blood pressure reading, this provides a meaningful baseline.
How HRT affects blood pressure: the nuance that most content misses
This is the question most women with elevated blood pressure and menopause symptoms eventually reach. The answer is more specific than most of what is written about it.
Transdermal HRT can have a neutral or slightly lowering effect on blood pressure. Patches, gels, and sprays deliver oestrogen directly into the bloodstream through the skin, bypassing the liver. The British Menopause Society's 2024 clinical toolkit on menopause management for women with cardiovascular disease is explicit on this point: transdermal oestrogen does not raise blood pressure. NICE NG23 (2024) recommends considering transdermal rather than oral HRT for women at increased cardiovascular or VTE risk, specifically because of this distinction.
Oral HRT tablets may mildly raise blood pressure in some women. Oral oestrogen passes through the liver before reaching the bloodstream, which affects how the body processes it. A 2024 systematic review and meta-analysis published in the journal Menopause examined the effect of HRT formulation and route of administration on blood pressure outcomes in postmenopausal women, confirming that route of delivery is clinically relevant. The practical implication: if you are on oral HRT and your blood pressure has risen since starting treatment, formulation is worth discussing with your specialist.
This distinction matters enormously for women with elevated blood pressure who are considering HRT. It means that high blood pressure is not a reason to avoid HRT altogether. It is a reason to ensure the right formulation is prescribed, which requires a specialist assessment rather than a generic recommendation.
Blood pressure should be controlled before starting HRT. The BMS (2024) guidance is clear that uncontrolled hypertension should be addressed before HRT is initiated. If your blood pressure is elevated and you are considering HRT, bringing it under control first, through lifestyle changes or medication, creates a safer starting point.
HRT and antihypertensives can be used together. Women on blood pressure medication are not automatically excluded from HRT. Transdermal HRT is generally compatible with antihypertensive therapy, and many women manage both. This combination should be overseen by a specialist who understands both the hormonal and cardiovascular picture.
This level of individual nuance is exactly why the HRT-and-blood-pressure question deserves more than a ten-minute GP appointment.
What actually helps: lifestyle changes with the evidence behind them
Lifestyle changes are genuinely effective for blood pressure management during menopause. They work best alongside appropriate clinical treatment rather than as a substitute for it.
Diet
The Mediterranean diet has the strongest evidence base for blood pressure reduction in menopausal women. A systematic review in AIMS Public Health (2024) found that Mediterranean diet adherence is associated with reductions in weight, blood pressure, triglycerides, and total and LDL cholesterol in menopausal women. A 2025 mini review in Frontiers in Nutrition, synthesising 42 high-quality studies, found that Mediterranean diet adherence consistently produced clinically meaningful reductions in blood pressure and triglyceride concentrations.
Practically: prioritise oily fish, vegetables, wholegrains, legumes, olive oil, and potassium-rich foods (bananas, leafy greens, sweet potato). Reduce salt, processed foods, and alcohol. These are not small-print recommendations: the effect sizes for dietary change on blood pressure are meaningful, particularly when combined with hormonal management.
Exercise
Regular aerobic and weight-bearing exercise supports blood pressure management through multiple pathways: improved vascular function, weight management, reduced stress response, and better sleep. Both the cardiovascular, bone health, psychological benefits are directly relevant here.
Sleep
Addressing sleep disruption is not just quality of life: it is cardiovascular care. The sympathetic nervous system activation that comes with poor sleep raises blood pressure directly. Effective treatment of vasomotor symptoms that disrupt sleep therefore has a downstream cardiovascular benefit.
Alcohol and smoking
Both raise blood pressure independently. Reducing alcohol also reduces hot flush frequency in many women, making it a doubly relevant recommendation.
The whole-plan effect
In Voy's outcome data, members on comprehensive treatment plans saw a 6.5% drop in systolic blood pressure (published in Cureus, 2025). 72% showed improvement in cholesterol, and more than 30% achieved full normalisation (published in Diabetes Obesity & Metabolism, 2025). These are population-level outcomes from Voy's member data, not individual guarantees. But they reflect what a properly supported, personalised approach to menopause care can produce for cardiovascular health.
Blood pressure medication: when it is needed and how it works alongside HRT
For some women, lifestyle changes and hormonal management will not be sufficient to bring blood pressure to a healthy range. Antihypertensive medications, including angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), and calcium channel blockers (CCBs), are effective, well-established, and widely prescribed. Choice of treatment can depend on: age, co-morbidities, other medication, and patient-preference
Taking blood pressure medication does not preclude HRT. Transdermal HRT is considered compatible with antihypertensive treatment, and many women manage both. The key is appropriate specialist oversight: a clinician who can monitor both blood pressure and hormonal status, adjust formulations where needed, and ensure that the two treatment elements are working in concert rather than being managed in separate clinical silos.
If you are on antihypertensives and have not yet discussed HRT, or if you are on oral HRT and your blood pressure has risen, these are exactly the questions to bring to a menopause specialist.
Getting the right support
The cardiovascular picture during menopause is more complex than a single blood pressure reading, and managing it well requires joined-up thinking: hormonal status, HRT formulation, lifestyle factors, medication interactions, and baseline cardiovascular markers all belong in the same conversation.
88% of Voy members felt more hormonally balanced at three months, compared to 62% receiving standard care (presented at The Menopause Society 2025, forthcoming in Climacteric). Hormonal stabilisation is not just about symptoms. It is about the downstream cardiovascular effects of getting the hormonal picture right.
Voy's menopause consultations are 45 minutes with BMS-trained (British Menopause Society) specialists: clinicians who have the time and expertise to take a full history, consider the HRT formulation question in the context of your cardiovascular risk profile, and build a treatment plan that addresses both your menopause symptoms and your longer-term health. Voy's Women's Midlife MOT Blood Test, measuring 16 biomarkers including a full lipid panel, provides a baseline that informs that conversation.
If your blood pressure has risen during perimenopause or menopause, that is not something to monitor alone. It is something to bring to a specialist who can see the whole picture.
